Seaport Therapeutics
PrivateLast Round
IPO Announced
Apr 10, 2026
Est. Valuation
$733M
Total Funding Raised
$325M
Company Overview
Seaport Therapeutics is a biopharmaceutical company focused on developing innovative neuropsychiatric medicines that address significant patient needs while providing oral bioavailability to minimize side effects and enhance patient quality of life.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Mental Health, Clinical Trials
Business Model
B2B2C
Customer Profile
Revenue Share
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Seaport Therapeutics Comps
Public and private peers based on sector, stage, and business model.
Seaport Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO Announced | Apr 10, 2026 | ||||
| Series B | Oct 21, 2024 | ||||
| Series A | Apr 9, 2024 |
Key People
Founding team and executive leadership
Seaport Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CPP Investments | Series B |
| Invus Opportunities | Series B |
| ARCH Venture Partners | Series B, Series A |
| Foresite Capital | Series B |
| T. Rowe Price | Series B |
| Goldman Sachs Group, Inc. | IPO |
| PureTech Health | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 10, 2026
$100M raised in IPO round.
- Mar 26, 2026
New oral drug delivery technology developed with Monash University.
Seaport Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Seaport Therapeutics's valuation, stock price, and market status.
